CSE’s Barrington Miller is rejoined by Alan Brochstein, founder of 420 Investor and contributor to New Cannabis Ventures, to discuss the recent issues surrounding the cannabis industry, with a specific focus on what’s happening in the United States and in the stock market.
In this wide-ranging discussion, Alan shares what he thinks are the two major “potholes” on the road to U.S. legalization (3:32), the issues presented by capital constraints in a booming business segment (7:04), the benefits for those that survive the current pandemic crisis in cannabis (10:39), and the industry’s transition from stigmatization to essential service (14:13).
Listen until the end to hear Alan’s thoughts on why banking and research are the next two issues that need to be addressed (18:39), the one mistake investors in U.S. cannabis routinely make (21:14), his biggest cannabis-related disappointment during the pandemic (22:27), the best (and worst) State cannabis rollouts (23:25), why it was important for the industry to shift away from ‘vertical integration’ (30:28), and how the industry will evolve through COVID-19.
New Cannabis Ventures
Disclaimer: The views, information, or opinions expressed during the podcast are solely those of the individuals involved and do not necessarily represent those of the Canadian Securities Exchange and its employees.
CSE’s Barrington Miller was recently joined by Christopher Moreau, CEO of Algernon Pharmaceuticals Inc. (CSE:AGN), to discuss his company’s work to develop NP-120 (Ifenprodil) as a new therapeutic in the fight against COVID-19.
In this discussion, Chris outlines how his company focuses on drug re-purposing, a term that is widely understood through the example provided by Viagra (1:04), the important distinction between therapeutic treatments and anti-virals and vaccines (12:14), and why the “grandaddy” of all market approvals is from the USFDA (18:25).
Listen until the end to hear how the company’s name is actually inspired by the title of a science fiction novel, and how the company has a history of investigating compounds developed by the Soviet Union!
(Subsequent to this chat, Algernon announced Health Canada approval to move forward with its PH2b/3 trial here with Ifenprodil as a potential treatment for COVID-19.)
CSE’s Grace Pedota recently chatted with Robyn Rabinovich, Senior Account Director, Cannabis at Hill+Knowlton Strategies, to reflect on her professional experiences in the rapidly evolving cannabis industry, dating back to the onset of the MMPR program in Canada.
In this comprehensive discussion, Robyn shares her favourite aspects of working at start-ups like CannTrust and TerrAscend (3:34), how Hill+Knowlton has uniquely positioned itself to provide B2B support to the industry (4:48), defining Cannabis 2.0 and what to expect from the 3.0 era (6:09), and her perspective on the Ontario cannabis retail situation amid COVID-19 shutdowns (11:54).
Listen until the end to hear her thoughts on how new technological applications are benefiting the cannabis industry, the prospects for consumption lounges in Toronto, and the new favourite quarantine pastime for those in the cannabis industry (hint: it’s not product consumption!)
CSE’s Anil Mall was recently joined by ePlay Digital Inc. (CSE:EPY) CEO Trevor Doerksen to discuss how his company is adapting to the recent conditions imposed by the Coronavirus, and how it inspired him to build a game that can help front line health care workers by supplying PPE (Personal Protective Equipment).
In this discussion, Trevor talks about his escape from LA during the outbreak of the COVID-19 pandemic (1:42), how current circumstances invigorated his mobile gaming project with Howie Mandel (6:43), and how he is leveraging his video game to drive donations to the #BreakoutTheMasks charity.
Listen until the end to hear more about Trevor’s unique collaboration with Howie Mandel, how the quarantine has dramatically impacted his flagship title – Big Shot, and how ePlay is adapting to release ‘quarantine-compatible’ games in the near future.
CSE’s Barrington Miller recently caught-up with NexTech AR Solutions Corp. (CSE:NTAR) CEO Evan Gappelberg to discuss his company’s current state of operations during the Coronavirus outbreak in NYC.
During this discussion, Evan provides commentary on the (positive) impact that the pandemic is having on his business (1:19), how their AR (augmented reality) technology fits within the shop-from home-paradigm (4:43), and his prospects for the stock market and predicted timeline for recovery (15:18).
Listen to the entire show to learn about Evan’s past history with Grand Theft Auto (the video game) and his positive experience taking a company public on the Canada Securities Exchange.
CSE’s James Black recently hosted Frank Holmes, CEO and CIO at U.S. Global Investors for his second visit to the #HashtagFinance podcast.
In this discussion Frank shares his many investment observations including the global themes that are contributing to gold price speculation (1:50), why he thinks buying Bitcoin is now analogous to collecting art (7:07), and the impact of Coronavirus on recent mining and investment conferences like PDAC (14:46).
Listen until the end to hear Frank’s thoughts on how safety and technology will evolve in response to the Coronavirus and how to protect your money in a low interest rate environment.